The Biden administration plans to provide $650 million to expand COVID-19 testing for elementary and middle schools, as well as homeless shelters and other underserved congregate settings, the White House said in a statement on Wednesday.
Japan will kick off its COVID-19 vaccination programme on Wednesday amid concerns that a shortage of special syringes could lead to the waste of millions of doses of Pfizer vaccine as the country grapples with its third and most serious wave of infections.
3 Min Read
TOKYO (Reuters) - Fears are growing in Japan, where an inoculation drive against COVID-19 will begin on Wednesday, that millions of doses of Pfizer vaccine could be wasted due to a shortage of special syringes that maximise the number of shots used from each vial.
FILE PHOTO: Pedestrians wearing protective masks amid the coronavirus disease (COVID-19) outbreak, make their way in Tokyo, Japan, February 2, 2021. REUTERS/Kim Kyung-Hoon/File Photo
The government has made urgent requests, but manufacturers are struggling to ramp up production fast enough, creating the latest headache for Prime Minister Yoshihide Suga, who suffers from weak public support.
A molecular test from Becton Dickinson that detects viruses that cause COVID-19 as well as influenza and produces result in 2-3 hours has been given emergency user authorization by the U.S. health regulator, the company said on Friday.
By Reuters Staff
2 Min Read
(Reuters) - Canadian digital healthcare company Well Health Technologies Corp said on Monday it would buy CRH Medical Corp for $292.7 million to expand into the United States, in a deal partly funded by its billionaire investor Li Ka-shing.
The move comes days after a unit of the Hong Kong tycoon’s CK Group agreed to buy two wind farms in British Columbia, marking its first purchase of a Canadian renewables project.
CRH Medical shareholders will get $4 per share in cash, representing a premium of about 83% to the company’s shares’ closing price on Friday.
U.S.-listed shares of CRH Medical were trading 80% higher at $3.94, while its Canada-listed shares were at C$5.02.